Gala vs Noom Med: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher & Publisher
Noom Med beats Gala overall, scoring 7.4/10 vs 7.2/10. Noom Med is more affordable at $79/mo vs $149/mo. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa. Choose Noom Med for users who want a low-dose glp-1 with biomarker monitoring an.
A side-by-side look at Gala and Noom Med to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Gala
#36 of 53Telehealth platform focused on compounded tirzepatide, both microdose and full-dose tiers, alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.
Visit GalaNoom Med
#25 of 53Noom restructured Noom Med in 2026 into a GLP-1 ladder plus a non-GLP-1 pill: Microdose GLP-1Rx at $79 then $199/mo, GLP-1Rx at $129 then $249/mo, GLP-1Rx Plus at $149 then $299/mo, and a metformin pill at $69 then $99/mo that is not a GLP-1. Verified 2026-07-27. Historic note: the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.
Visit Noom Med| Feature | Gala | Noom Med |
|---|---|---|
| Why each one | The dedicated 'Gala GLP-1 Tracker' app on BOTH iOS and Android, paired with the cheapest microdose tirzepatide tier ($149/mo) on a tracked telehealth platform, most compounded-only platforms offer neither a first-party tracking experience nor an explicit microdose pricing tier. | The only GLP-1 platform built on a decade of behavioral psychology research, combining medication with Noom's proven coaching methodology for lasting habit change. |
| Our Score | 7.2/10 | 7.4/10 |
| Starting Price | $149/mo | $79/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging | Users who want a low-dose GLP-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing |
| Watch out for | Brand-name Ozempic here is $1,299/mo, materially above market (NovoCare direct pricing for Wegovy is $349/mo; Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership). Buy brand-name elsewhere, Gala's value is its compounded tirzepatide. | Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27] |
| Ranking | #36 | #25 |
| Get started | Visit Gala | Visit Noom Med |
Pros & Cons Compared
Gala
Pros
- +Microdose compounded tirzepatide at $149/mo, the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
- +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android, first-party in-treatment logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic here is $1,299/mo, materially above market (NovoCare direct pricing for Wegovy is $349/mo; Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership). Buy brand-name elsewhere, Gala's value is its compounded tirzepatide.
- −Tirzepatide-only on the compounded side, compounded semaglutide is NOT offered, a narrower medication menu than peers like Maximus, Ro, or Henry Meds
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
- −Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and there are no published labs, no named medical director, no specialty obesity oversight
- −Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
Noom Med
Pros
- +Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
- +Microdose GLP-1Rx is $79 for the first 4 weeks then $199/mo billed quarterly, low-dose GLP-1 plus biomarker monitoring for side-effect-sensitive users [Verified 2026-07-27]
- +Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
- +Industry-leading behavioral coaching app with years of psychology-based weight loss methodology
Cons
- −Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27]
- −Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
- −Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
- −App coaching still requires real engagement, skip-prone users waste the behavioral value
Our Verdict
Noom Med edges out Gala with a score of 7.4/10 vs 7.2/10. If budget is your priority, Noom Med is $79/mo for the first month, then $199/mo compared to Gala from $149/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging. Choose Noom Med if you want: users who want a low-dose glp-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing.
Read Full Reviews
Related comparisons
Other matchups readers comparing Gala or Noom Med tend to look at next.
- Gala vs MEDVi$179/mo
- Gala vs Found$129/mo
- Gala vs TMates$158/mo
- Noom Med vs WeightWatchers (Sequence)$74/mo
- Noom Med vs Sprout Health$199/mo
- Noom Med vs Enhance MD$212/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Noom Med · 7.4/10